In this study, 11 patients were injected with Volbella XC into the tear trough region and subsequently underwent undereye volumetric measurements over a 90-day period.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are widely used for Type 2 diabetes and weight management but may adversely affect skin quality, resulting in dermal thinning, decreased elasticity, and accelerated aging—a phenomenon referred to as “GLP-1 Face.”
In this update, Dr. Pfeifer talks about the upcoming program planning for Aesthetic Interactive: Facial & Rhinoplasty Symposium in Boca Raton, Florida, and The Aesthetic MEET in Boston, Massachusetts, recapping the May Master Class with Dr. Calobrace, and her upcoming trips to Monaco, New England, and Singapore!